ES2014518A6 - Sustained release composition - Google Patents

Sustained release composition

Info

Publication number
ES2014518A6
ES2014518A6 ES8702873A ES8702873A ES2014518A6 ES 2014518 A6 ES2014518 A6 ES 2014518A6 ES 8702873 A ES8702873 A ES 8702873A ES 8702873 A ES8702873 A ES 8702873A ES 2014518 A6 ES2014518 A6 ES 2014518A6
Authority
ES
Spain
Prior art keywords
sustained release
release composition
mixed
active agent
pregelatimized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8702873A
Other languages
Spanish (es)
Inventor
Henry C Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2014518A6 publication Critical patent/ES2014518A6/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UNA COMPOSICION FARMACEUTICA DE LIBERACION RETARDADA, CARACTERIZADO PORQUE SE MEZCLA UN AGENTE ACTIVO FARMACOLOGICAMENTE CON: A) UNA CELULOSA MICROCRISTALINA, Y B) CON HIDROXIPROPIL-METILCELULOSA, LA RELACION EN PESO ENTRE A) Y B) SIENDO POR LO MENOS DE 1 A 1, CON LA CONDICION DE QUE CUANDO EL AGENTE ACTIVO ES DISTINTO DE ACIDO ACETILSALICILICO, SE MEZCLA TAMBIEN ALMIDON PREGELATIMIZADO.PROCEDURE FOR THE PRODUCTION OF A DELAYED PHARMACEUTICAL COMPOSITION, CHARACTERIZED BECAUSE A PHARMACOLOGICALLY ACTIVE AGENT IS MIXED WITH: A) A CELLULOSE MICROCRYSTALLINE, AND B) WITH HYDROXYPROPYL-METHYL CELLULOSE, THE RELATION IN PORES AND AESO A 1, WITH THE CONDITION THAT WHEN THE ACTIVE AGENT IS OTHER THAN ACETYLSALICILIC ACID, IT IS ALSO MIXED WITH PREGELATIMIZED STARCH.

ES8702873A 1986-10-09 1987-10-08 Sustained release composition Expired - Lifetime ES2014518A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2014518A6 true ES2014518A6 (en) 1990-07-16

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702873A Expired - Lifetime ES2014518A6 (en) 1986-10-09 1987-10-08 Sustained release composition

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A7 (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
ES2255490T3 (en) * 1999-03-31 2006-07-01 Janssen Pharmaceutica N.V. PREGELATINIZED ALMIDON IN A CONTROLLED RELEASE FORMULATION.
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
PT1803447E (en) * 2004-09-09 2009-08-14 Psicofarma S A De C V Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (en) * 1972-02-22 1973-08-22 Lilly Co Eli PROPOXYPHENE DELAY NAPSYLATE PARTICLES AND PROCESS FOR MANUFACTURING SUCH PARTICLES
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
NO874200D0 (en) 1987-10-07
HUT52958A (en) 1990-09-28
FI874414L (en) 1988-04-10
GB2195893A (en) 1988-04-20
KR880004801A (en) 1988-06-27
IT8748469A0 (en) 1987-10-08
SE8703889L (en) 1988-04-10
FI874414A0 (en) 1987-10-07
FR2604902A1 (en) 1988-04-15
HU201875B (en) 1991-01-28
ZA877617B (en) 1989-05-30
PT85880A (en) 1987-11-01
DK527487A (en) 1988-04-10
IT1221493B (en) 1990-07-06
FI874414A7 (en) 1988-04-10
NO874200L (en) 1988-04-11
LU87009A1 (en) 1988-05-03
CA1332809C (en) 1994-11-01
PH24227A (en) 1990-05-04
IL84104A0 (en) 1988-03-31
PT85880B (en) 1990-07-31
NZ222083A (en) 1991-05-28
BE1000732A5 (en) 1989-03-21
SE8703889D0 (en) 1987-10-08
AU7942087A (en) 1988-04-14
JPS63101334A (en) 1988-05-06
GB8723515D0 (en) 1987-11-11
DE3733540A1 (en) 1988-04-14
GB2195893B (en) 1991-05-08
FR2604902B1 (en) 1991-04-26
CH675831A5 (en) 1990-11-15
GR871550B (en) 1988-02-15
DK527487D0 (en) 1987-10-08
NL8702294A (en) 1988-05-02
GB8624213D0 (en) 1986-11-12

Similar Documents

Publication Publication Date Title
ES2042541T4 (en) A PROCEDURE FOR PREPARING A DELAYED PHARMACEUTICAL FORMULATION CONTAINING XANTHANE GUM.
ES2010226A6 (en) A PROCEDURE FOR PRODUCING A STABLE PHARMACEUTICAL PREPARATION CONTAINING A STIMULATING FACTOR OF GRANULOCYTE COLONIES
ATE66143T1 (en) SLOW RELEASE SOLID PREPARATION.
ES2128369T3 (en) PROCEDURE FOR THE MANUFACTURE OF SOLID PHARMACEUTICAL FORMS WITH PROLONGED RELEASE IN TWO STAGES.
FI820467L (en) PHARMACEUTICAL COMPOSITION SOM FRIGOERS KONTINUERLIGT
BG103047A (en) Granulate for the preparation of quick decomposition and quick dissolving compositions having high medicamentous form content
AR080436A2 (en) SOLID PREPARATION FOR QUICK DISINTEGRATION, USE OF A LITTLE HYDROXYPROPILCELULOSE IN SUCH PREPARATION AND METHOD TO IMPROVE THE ORAL DISINTEGRABILITY OF THE SAME
IE873213L (en) Galenical Formulation
ES2019398B3 (en) NEW COMPOSITION FOR FEEDING RUMINANTS, CONTAINING A BIOLOGICALLY ACTIVE SUBSTANCE AND ITS PREPARATION.
ES2026198T3 (en) COMPOSITE BASED ON SOLID VALPROIC ACID, STABLE TO HUMIDITY AND METHOD FOR ITS PREPARATION.
DE69230475D1 (en) Delayed release matrix for drugs
ATE91232T1 (en) HYDROXYPROPYLCELLULOSIC ETHER DELAYED RELEASE AGENTS.
ES2037385T3 (en) A MANUFACTURING PROCEDURE OF A PHARMACEUTICAL PREPARATION FOR LOCAL ADMINISTRATION.
KR900012606A (en) Double tablets
ES2062206T3 (en) STABILIZED COMPOSITION OF FGF AND ITS PRODUCTION.
NO863916L (en) PHARMACEUTICAL MATERIALS OF THE TYPE THROUGH A LIQUID-PHASE PHASE CONVERSION.
ES2130638T3 (en) SYSTEM FOR THE RELEASE OF ACTIVE SUBSTANCE, FILMOGEN, VAPORIZABLE, FOR USE IN PLANTS.
ES2060737T3 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL GRANULATE.
ES2038643T3 (en) PROCEDURE FOR OBTAINING A TOPIC PHARMACEUTICAL COMPOSITION.
EG18379A (en) Novel pharmacological compounds
ES2111547T3 (en) PROLONGED RELEASE TABLET.
ES2014518A6 (en) Sustained release composition
UY24308A1 (en) BINDER-FREE TABLETS CONTAINING TRAMADOL OR A SALT OF TRAMADOL, FOR ORAL ADMINISTRATION
DK0460062T3 (en) Huperzin A analogues
AR018607A1 (en) PHARMACEUTICAL PREPARATION THAT IN QUALITY OF ACTIVE INGREDIENT CONTAINS SODIUM LEVOTIROXIN, AND A PROCEDURE FOR ITS PREPARATION

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204